Ringborg U - Search Results

1

The value of cysteinyldopa in the follow-up of disseminated malignant melanoma.

Kärnell R, Kågedal B, Lindholm C, Nilsson B, Arstrand K, Ringborg U. Kärnell R, et al. Among authors: ringborg u. Melanoma Res. 2000 Aug;10(4):363-9. doi: 10.1097/00008390-200008000-00008. Melanoma Res. 2000. PMID: 10985671

2

Prognostic value of serum analyses of S-100 beta protein in malignant melanoma.

von Schoultz E, Hansson LO, Djureen E, Hansson J, Kärnell R, Nilsson B, Stigbrand T, Ringborg U. von Schoultz E, et al. Among authors: ringborg u. Melanoma Res. 1996 Apr;6(2):133-7. doi: 10.1097/00008390-199604000-00008. Melanoma Res. 1996. PMID: 8791271

3

Prognostic value of serum analyses of S-100 protein beta in malignant melanoma.

Hansson LO, von Schoultz E, Djureen E, Hansson J, Nilsson B, Ringborg U. Hansson LO, et al. Among authors: ringborg u. Anticancer Res. 1997 Jul-Aug;17(4B):3071-3. Anticancer Res. 1997. PMID: 9329604

4

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features.

Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlöf B, Nilsson BR, Ringborg UK. Ragnarsson-Olding BK, et al. Among authors: ringborg uk. Cancer. 1999 Oct 1;86(7):1273-84. Cancer. 1999. PMID: 10506714

5

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival.

Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlöf B, Ringborg UK. Ragnarsson-Olding BK, et al. Among authors: ringborg uk. Cancer. 1999 Oct 1;86(7):1285-93. Cancer. 1999. PMID: 10506715

6

Screening for cutaneous malignant melanoma: a feasibility study.

Törnberg S, Månsson-Brahme E, Lindén D, Ringborg U, Krakau I, Kärnell R, Landegren J, Brandberg Y, Hakulinen T. Törnberg S, et al. Among authors: ringborg u. J Med Screen. 1996;3(4):211-5. doi: 10.1177/096914139600300411. J Med Screen. 1996. PMID: 9041488 Clinical Trial.

7

Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.

Mårtenson ED, Hansson LO, Nilsson B, von Schoultz E, Månsson Brahme E, Ringborg U, Hansson J. Mårtenson ED, et al. Among authors: ringborg u. J Clin Oncol. 2001 Feb 1;19(3):824-31. doi: 10.1200/JCO.2001.19.3.824. J Clin Oncol. 2001. PMID: 11157036

8

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.

Ma S, Egyházi S, Ueno T, Lindholm C, Kreklau EL, Stierner U, Ringborg U, Hansson J. Ma S, et al. Among authors: ringborg u. Br J Cancer. 2003 Oct 20;89(8):1517-23. doi: 10.1038/sj.bjc.6601270. Br J Cancer. 2003. PMID: 14562026 Free PMC article.

9

Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.

Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B. Hansson J, et al. Among authors: ringborg u. Cancer Res. 1988 Jan 1;48(1):19-26. Cancer Res. 1988. PMID: 3334994

10

Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm.

Cohn-Cedermark G, Rutqvist LE, Andersson R, Breivald M, Ingvar C, Johansson H, Jönsson PE, Krysander L, Lindholm C, Ringborg U. Cohn-Cedermark G, et al. Among authors: ringborg u. Cancer. 2000 Oct 1;89(7):1495-501. Cancer. 2000. PMID: 11013363 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters